masitinib
Showing 1 - 22 of 22
SARS-CoV 2, COVID-19, Coronavirus Disease 2019 Trial in France (Masitinib, Isoquercetin, Best Supportive Care)
Recruiting
- SARS-CoV 2
- +2 more
- Masitinib
- +2 more
-
Aix-en-Provence, France
- +5 more
Jun 20, 2022
Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)
Recruiting
- Indolent Systemic Mastocytosis
- Masitinib
- +2 more
-
Rochester, Minnesota
- +6 more
Nov 29, 2021
Metastatic Castrate Resistant Prostate Cancer Trial in Worldwide (Masitinib, Docetaxel, Prednisone)
Completed
- Metastatic Castrate Resistant Prostate Cancer
- Masitinib
- +3 more
-
Sherbrooke, Canada
- +8 more
Jun 3, 2021
Colorectal Cancer Metastatic Trial in Worldwide (Masitinib)
Completed
- Colorectal Cancer Metastatic
- Masitinib
-
Olomouc, Czechia
- +4 more
Dec 7, 2020
Asthma Trial in Worldwide (Masitinib, Placebo)
Completed
- Asthma
- Masitinib
- Placebo
-
Pleven, Bulgaria
- +7 more
Feb 9, 2021
Alzheimer Trial in Worldwide (Masitinib, Placebo)
Completed
- Alzheimer Disease
- Masitinib
- Placebo
-
Varna, Bulgaria
- +5 more
Dec 7, 2020
Asthma Trial in Worldwide (Masitinib, Placebo)
Completed
- Asthma
- Masitinib
- Placebo
-
Buenos Aires, Argentina
- +4 more
Dec 7, 2020
Gastrointestinal Stromal Tumors Trial in Worldwide (Masitinib, Sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- Masitinib
- Sunitinib
-
Saint Louis, Missouri
- +4 more
Dec 7, 2020
Ovarian Cancer Trial in Worldwide (Masitinib, Gemcitabine, Placebo)
Completed
- Ovarian Cancer
- Masitinib
- +2 more
-
Algiers, Algeria
- +5 more
Dec 7, 2020
Locally Advanced or Metastatic Pancreatic Cancer Trial in Worldwide (Masitinib, Gemcitabine, Placebo)
Completed
- Locally Advanced or Metastatic Pancreatic Cancer
- Masitinib
- +2 more
-
Brugge, Belgium
- +8 more
Dec 7, 2020
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapse Free Trial in
Completed
- Multiple Sclerosis, Secondary Progressive
- +2 more
- Masitinib
- Placebo
-
Sofia, Bulgaria
- +7 more
Apr 3, 2020
Indolent Systemic Mastocytosis Trial in France, United States (Masitinib, Placebo, Best Supportive Care)
Completed
- Indolent Systemic Mastocytosis
- Masitinib
- +2 more
-
Sacramento, California
- +23 more
Nov 29, 2019
Gastro-Intestinal Stromal Tumour Trial (Masitinib, Placebo)
Terminated
- Gastro-Intestinal Stromal Tumour
- Masitinib
- Placebo
- (no location specified)
Dec 12, 2018
Gastro Intestinal Stromal Tumor Trial in Villejuif (masitinib, sunitinib)
Completed
- Gastro Intestinal Stromal Tumor
- masitinib
- sunitinib
-
Villejuif, FranceInstitute Gustave Roussy (IGR)
Dec 8, 2018
Multiple Sclerosis Trial (masitinib)
Completed
- Multiple Sclerosis
- masitinib
- (no location specified)
Dec 8, 2018
Rheumatoid Arthritis Trial (masitinib)
Completed
- Rheumatoid Arthritis
- masitinib
- (no location specified)
Dec 12, 2018
Mastocytosis Trial (masitinib)
Completed
- Mastocytosis
- masitinib
- (no location specified)
Dec 6, 2018
Psoriasis Trial (Masitinib, Placebo)
Completed
- Psoriasis
- Masitinib
- Placebo
- (no location specified)
Dec 6, 2018
Multiple Myeloma Trial in France, United States (Masitinib, Placebo, Bortezomib)
Terminated
- Multiple Myeloma
- Masitinib
- +3 more
-
Galesburg, Illinois
- +12 more
Dec 17, 2018
Pancreatic Cancer Trial in Worldwide (Masitinib, Placebo, Gemcitabine)
Completed
- Pancreatic Cancer
- Masitinib
- +2 more
-
Norwich, Connecticut
- +67 more
Dec 13, 2018